---
figid: PMC10377043__biomedicines-11-02054-g004
pmcid: PMC10377043
image_filename: biomedicines-11-02054-g004.jpg
figure_link: /pmc/articles/PMC10377043/figure/biomedicines-11-02054-f004/
number: Figure 4
figure_title: ''
caption: Prototypic small molecule inhibitor screen coupled with CRISPR-activated
  lncRNAs. Heat map showing cell survival of induced lncRNA candidates using best
  sgRNAs in response to various cellular pathway inhibitors normalized to sgNegCtrl
  and DMSO as 100%. EGFR induction serves as positive control.
article_title: Integrative CRISPR Activation and Small Molecule Inhibitor Screening
  for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma.
citation: Sama Shamloo, et al. Biomedicines. 2023 Jul;11(7):2054.
year: '2023'

doi: 10.3390/biomedicines11072054
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI

keywords:
- lncRNA
- melanoma
- drug resistance
- CRISPR activation
- small molecule inhibitor

---
